文献速递免疫规划卫生政策与健康促进

东地中海区域卫生经济学与疫苗筹资:一项需求评估

Health economics and vaccine financing in the eastern Mediterranean region: A needs assessment.
PubMed 文献 · Vaccine · 2025-09-25

2025年1月28日至2月18日对东地中海区域22国免疫规划管理者与NITAG主席开展结构化在线调查,应答率73%(16/22)。仅3国(19%)将卫生经济学完全整合进免疫规划,11国(69%)在成本效果分析与疫苗财务可持续性方面自评能力低或无,结论强调需 tailored 能力建设与技术合作。

要点

  • 应答率73%(16/22国),仅3国(19%)报告卫生经济学完全整合进免疫规划。
  • 11国(69%)自评成本效果分析与疫苗财务可持续性能力为低或无。
  • 10国(63%)自评财务预测与规划能力为中或高,25%国家数据易获取。

核心结论

  • 研究结果凸显需在整个东地中海区域加强将卫生经济学与疫苗筹资纳入免疫规划和政策决策,与收入水平无关。
  • 作者认为量身定制的能力建设、技术支持及跨部门合作(尤其与学术界)至关重要。

研究设计与样本

  • 2025年1月28日至2月18日开展结构化在线调查,覆盖全部22个东地中海区域国家的免疫规划管理者与NITAG主席。
  • 调查含五主题:卫生经济学与疫苗筹资现有能力、培训与能力建设需求、技术支持需求、数据可及性与决策使用、卫生部与NITAG免疫利益相关方的疫苗筹资战略规划。
  • 采用多选题、Likert量表和开放式问题,结果以描述性统计并按收入水平分层分析。

主要发现

  • 应答率73%(16/22国);仅3国(19%)报告卫生经济学完全整合进免疫规划,56%(n=9)报告极少或无整合。
  • 3国有免疫专属卫生经济学联络人;两个高收入国家免疫规划卫生经济学能力较强,其余国家为低至中等水平。
  • 10国(63%)自评财务预测与规划能力为中或高,但11国(69%)自评成本效果分析与疫苗财务可持续性能力为低或无。
  • 数据可及性不一,25%国家认为数据易获取。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The World Health Organization Eastern Mediterranean Region (EMR) faces a high burden of vaccine-preventable diseases requiring efficient use of limited resources. A regional needs assessment was conducted to evaluate the current application of health economics and vaccine financing in national immunization programmes and policy formulation, identify capacity gaps, and inform tailored technical support. METHODS: A structured online survey was administered between January 28 and February 18, 2025. It targeted expended programme on immunization (EPI) managers and National Immunization Technical Advisory Group (NITAG) chairs across all 22 EMR countries. The questionnaire explored five thematic areas: current capacity in health economics and vaccine financing, training and capacity-building needs, demand for technical support, data availability and use in decision-making, and strategic planning for vaccine financing among immunization stakeholders at Ministry of Health and in NITAGs. The survey used multiple-choice, Likert-scale, and open-ended questions. Results were analyzed using descriptive statistics and disaggregated by income level. RESULTS: The response rate was 73 % (16/22 countries). Only three countries (19 %) reported full integration of health economics within their immunization programmes, while 56 % (n = 9) reported minimal or no integration. Three countries had a dedicated health economics focal person for immunization. In two high-income countries immunization programmes demonstrated stronger capacity in health economics, whereas the rest of countries demonstrated low to moderate levels. Ten countries (63 %) rated their capacity in financial forecasting and planning for immunization as moderate or high, but eleven (69 %) rated their capacity in cost-effectiveness analysis and vaccine financial sustainability as low to none. Access to data varied, with 25 % of countries finding it easily accessible. CONCLUSION: The findings highlight the need to strengthen the integration of health economics and vaccine financing into immunization programmes and policy decision-making across the EMR, irrespective of income level. Tailored capacity-building, technical support, and cross-sectoral collaboration, particularly with academia, are essential.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Anwari P, Sume G, Meshreky W, et al. Health economics and vaccine financing in the eastern Mediterranean region: A needs assessment. Vaccine. 2025. PMID: 41004947. doi:10.1016/j.vaccine.2025.127780

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。